NuCana (NASDAQ: NCNA) CEO Hugh S. Griffith returns from health leave
Rhea-AI Filing Summary
NuCana plc reports that Hugh S. Griffith has returned to his role as Chief Executive Officer and principal executive officer, effective December 15, 2025.
During his health-related leave, Executive Chairman Andrew Kay had been acting as the company’s principal executive officer; upon Mr. Griffith’s return, Mr. Kay resumed his prior position as Chairman of the Board. The update is also stated to be incorporated by reference into NuCana’s existing shelf and equity compensation registration statements on Form F-3 and Form S-8.
Positive
- None.
Negative
- None.
FAQ
What leadership change did NuCana plc (NCNA) disclose in this report?
NuCana disclosed that Hugh S. Griffith has returned to his role as Chief Executive Officer and principal executive officer. He had previously been on a health-related leave of absence.
When did Hugh S. Griffith resume his role as NuCana CEO?
The report states that Hugh S. Griffith resumed his role as Chief Executive Officer and principal executive officer of NuCana plc effective December 15, 2025.
What is Andrew Kay’s position at NuCana after this change?
After Hugh S. Griffith’s return, Andrew Kay moved from serving as Executive Chairman and acting principal executive officer back to his prior role as Chairman of the Board.
Why had Hugh S. Griffith taken a leave of absence from NuCana?
The report notes that, as previously disclosed in June 2025, Hugh S. Griffith took a leave of absence from NuCana for health reasons.
How is this corporate update used in NuCana’s SEC registration statements?
The corporate update is stated to be incorporated by reference into NuCana’s registration statements on Form F-3 (File No. 333-281576) and Form S-8 (File Nos. 333-223476 and 333-248135), becoming part of those documents from the date this report is filed.